603235 天新药业
2026/06 - 中期
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额383,577629,362499,656729,212606,613
投资活动产生之现金流量净额(282,637)(89,497)(1,540,670)(303,146)(455,342)
筹资活动产生之现金流量净额51,851(39,586)(240,193)(215,595)1,162,448
汇率变动对现金及现金等价物的影响(30,637)(8,967)51,70627,76863,374
现金及现金等价物净增加/(减少)122,155491,313(1,229,502)238,2401,377,094
期初现金及现金等价物余额1,569,5801,078,2672,307,7692,069,529692,436
期末现金及现金等价物余额1,691,7351,569,5801,078,2672,307,7692,069,529